WCN24-828 PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
Saved in:
| Main Authors: | Rocio Soldati, Sasha Sreckovic, Cristian Brocchieri, Patty Leon, Nadiesh Balachandran, Marianne Uguen, Simon Buatois |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924011926 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crovalimab: A Novel Approach in the Management of Paroxysmal Nocturnal Hemoglobinuria
by: Laiba Jalal, et al.
Published: (2025-07-01) -
Diagnostic Challenge of Paroxysmal Nocturnal Hemoglobinuria (PNH) with Aplastic Anemia: A Case Report
by: Priyanshi Maurya, et al.
Published: (2025-01-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01) -
WCN24-461 RAPID COMPLEMENT INHIBITION WITH THE C5 INHIBITOR CROVALIMAB: TIMING ANALYSIS USING ANIMAL MODEL AND COMPOSER TRIAL DATA
by: Rocio Soldati, et al.
Published: (2024-04-01) -
Paroxysmal nocturnal hemoglobinuria: Pandora’s box?
by: Mihnea-Alexandru Găman, et al.
Published: (2020-10-01)